BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10755995)

  • 1. Urinary glycosaminoglycan excretion in urolithiasis.
    Harangi F; Györke Z; Melech B
    Arch Dis Child; 2000 Jan; 82(1):88. PubMed ID: 10755995
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary glycosaminoglycan excretion in urolithiasis.
    Akçay T; Konukoğlu D; Dínçer Y
    Arch Dis Child; 1999 Mar; 80(3):271-2. PubMed ID: 10325710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Observation on urinary glycosaminoglycan excretion in patients with urinary calculus in relation to the nature of organic matrix of calculi].
    Baba S; Nakazawa K; Odajima K; Fujioka T; Nakamura H
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):608-15. PubMed ID: 6413740
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycosaminoglycans in urolithiasis.
    Nesse A; Garbossa G; Romero MC; Bogado CE; Zanchetta JR
    Nephron; 1992; 62(1):36-9. PubMed ID: 1436289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique.
    Samuell CT
    Clin Chim Acta; 1981 Nov; 117(1):63-73. PubMed ID: 7333013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
    Nikkilä MT
    Urol Int; 1989; 44(3):157-9. PubMed ID: 2749930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Level of acid mucopolysaccharides in the urine in urolithiasis].
    Vaĭnberg ZS; Gimpel'son IaE; Shaposhnikov IuA
    Eksp Khir Anesteziol; 1970; 15(4):22-4. PubMed ID: 4252999
    [No Abstract]   [Full Text] [Related]  

  • 8. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
    Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of mucopolysaccharide elimination in urolithiasis].
    Hesse A; Hartmann U; Schneider HJ; Horn G
    Z Urol Nephrol; 1975 Jun; 70(6):401-5. PubMed ID: 127480
    [No Abstract]   [Full Text] [Related]  

  • 10. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.
    Conte A; Roca P; Genestar C; Grases F
    Nephron; 1989; 52(2):162-5. PubMed ID: 2500615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocitraturia in patients with urolithiasis.
    Hoppe B; Langman CB
    Arch Dis Child; 1997 Feb; 76(2):174-5. PubMed ID: 9068316
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro studies on the role of glycosaminoglycans in crystallization intensity during infectious urinary stones formation.
    Torzewska A; Różalski A
    APMIS; 2014 Jun; 122(6):505-11. PubMed ID: 24164670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theories concerning the formation of urinary calculi].
    Głuszek J; Grajek S
    Pol Tyg Lek; 1978 Jun; 33(25):1011-4. PubMed ID: 151272
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary glycosaminoglycan excretion in newly diagnosed essential hypertensive patients.
    Yavuz D; Toprak A; Budak Y; Ersöz HO; Deyneli O; Tezcan H; Akalin S
    Clin Chem; 2000 Feb; 46(2):299-301. PubMed ID: 10657395
    [No Abstract]   [Full Text] [Related]  

  • 16. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycans as inhibitors of stone formation.
    Sallis JD
    Miner Electrolyte Metab; 1987; 13(4):273-7. PubMed ID: 3306320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [24-hour urinary oxalate excretion in healthy children and in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Wawrzyszuk M; Zajaczkowska M
    Pol Merkur Lekarski; 2008; 24 Suppl 4():76-9. PubMed ID: 18924510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of acute acidifying loading on urinary calcium excretion in healthy children and children with pyelonephritis and urolithiasis].
    Bittner K; Maciejewski J; Bortkiewicz E; Fojudzki E
    Pediatr Pol; 1974 Dec; 49(12):1519-24. PubMed ID: 4431654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.